
Michael Seid, PhD
Advertisement
Articles by Michael Seid, PhD
Advertisement
Latest Updated Articles
All Things Considered, the Answer Is a Resounding YesJanuary 15th 2008
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis
3
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
4
ICER Draft Flags High Cost of New Hypertension Drug Class
5